Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dyslipidemia

  Free Subscription


Articles published in Postgrad Med

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    June 2018
  1. FRANKOVA D, Olson KM, Whyms BJ, Guevara Hernandez MA, et al
    The effect of intravenous insulin, apheresis and oral lipid-lowering agents on non-fasting hypertriglyceridemia and associated pancreatitis.
    Postgrad Med. 2018;130:494-500.
    PubMed     Text format     Abstract available


    April 2018
  2. FONTELA C, Castilla J, Juanbeltz R, Martinez-Baz I, et al
    Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
    Postgrad Med. 2018;130:317-324.
    PubMed     Text format     Abstract available


  3. POKRYWKA GS
    PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option.
    Postgrad Med. 2018;130:287-298.
    PubMed     Text format     Abstract available


    March 2018
  4. MAKI KC, Diwadkar-Navsariwala V, Kramer MW
    Statin use and risk for type 2 diabetes: what clinicians should know.
    Postgrad Med. 2018;130:166-172.
    PubMed     Text format     Abstract available


    January 2018
  5. ZHOU J, Zhang Q, Wang Y, Gao P, et al
    The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.
    Postgrad Med. 2018;130:129-136.
    PubMed     Text format     Abstract available


    November 2017
  6. NELSON JR, True WS, Le V, Mason RP, et al
    Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?
    Postgrad Med. 2017;129:822-827.
    PubMed     Text format     Abstract available


  7. WOJCIK C
    Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease.
    Postgrad Med. 2017;129:801-810.
    PubMed     Text format     Abstract available


    April 2017
  8. UNAL S, Tanriover MD, Ascioglu S, Demirkazik A, et al
    Turkish doctors' cohort: healthy despite low screening.
    Postgrad Med. 2017;129:393-398.
    PubMed     Text format     Abstract available


    March 2017
  9. KARAGOZ A, Onat A, Aydin M, Can G, et al
    Distinction of hypertriglyceridemic waist phenotype from simple abdominal obesity: interaction with sex hormone-binding globulin levels to confer high coronary risk.
    Postgrad Med. 2017;129:288-295.
    PubMed     Text format     Abstract available


    November 2016
  10. KUSHNER PA, Cobble ME
    Hypertriglyceridemia: the importance of identifying patients at risk.
    Postgrad Med. 2016;128:848-858.
    PubMed     Text format     Abstract available


  11. SU BY, Tian CF, Gao BL, Tong YH, et al
    Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
    Postgrad Med. 2016;128:805-809.
    PubMed     Text format     Abstract available


  12. CRANDELL JR, Tartaglia C, Tartaglia J
    Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients.
    Postgrad Med. 2016;128:859-864.
    PubMed     Text format     Abstract available


  13. CHEN K, Li P, Li YJ, Li T, et al
    Sex disparity in the association between hypertriglyceridemic waist phenotype and arterial stiffness in Chinese healthy subjects.
    Postgrad Med. 2016;128:783-789.
    PubMed     Text format     Abstract available


    October 2016
  14. SABATINE MS, Underberg JA, Koren M, Baum SJ, et al
    Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice.
    Postgrad Med. 2016;128 Suppl 1:31-9.
    PubMed     Text format     Abstract available


  15. CERRATO P, Mihalovic M
    The 10(th) Annual Cardiometabolic Health Congress General Session Highlights.
    Postgrad Med. 2016;128 Suppl 1:1-10.
    PubMed     Text format    


    May 2016
  16. ANGLADA-MARTINEZ H, Rovira-Illamola M, Martin-Conde M, Sotoca-Momblona JM, et al
    mHealth intervention to improve medication management in chronically ill patients: analysis of the recruitment process.
    Postgrad Med. 2016;128:427-31.
    PubMed     Text format     Abstract available


    June 2015
  17. BINDLISH S, Presswala LS, Schwartz F
    Lipodystrophy: Syndrome of severe insulin resistance.
    Postgrad Med. 2015;127:511-6.
    PubMed     Text format     Abstract available


    March 2015
  18. KOREN MJ, Roth EM, McKenney JM, Gipe D, et al
    Safety and efficacy of alirocumab 150 mg every 2 weeks, a fully human proprotein convertase subtilisin/kexin type 9 monoclonal antibody: A Phase II pooled analysis.
    Postgrad Med. 2015;127:125-32.
    PubMed     Text format     Abstract available


    January 2015
  19. KEDIA AW, Lynch E
    Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
    Postgrad Med. 2015;127:869-73.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: